血液透析中心与血管通路外科医生的合作关系与中心静脉导管使用:回顾性队列研究
该回顾性队列研究纳入109,293例维持性血液透析的肾衰竭患者,分布於4,402家透析中心,采用设施层面的赫芬达尔-赫希曼指数(HHI)作为透析中心与血管通路外科医生合作紧密度的代理指标。结果显示,HHI最高四分位组患者持续使用中心静脉导管超过90天的 odds 比最低四分位组低(OR 0.80, 95%CI 0.75-0.87, P<0.001),提示更紧密的合作关系与更低的导管使用率相关。
要点
- 透析中心与血管通路外科医生合作越紧密,患者长期使用中心静脉导管的风险越低。
- HHI最高四分位组较最低组持续导管使用>90天的OR为0.80(95%CI 0.75-0.87)。
- 该关联在多项敏感性分析中一致,提示合作模式可能改善血管通路管理。
核心结论
- 透析中心与血管通路外科医生之间更广泛的合作关系(以HHI衡量)与维持性血液透析患者中心静脉导管使用率降低相关。
研究设计与样本
- 全国性回顾性队列研究,纳入109,293例接受维持性血液透析的肾衰竭患者,分布于4,402家透析中心。
- 暴露为设施层面的赫芬达尔-赫希曼指数(HHI),作为透析中心与血管通路外科医生合作紧密度的代理指标。
- 采用混合效应逻辑回归模型,纳入患者层面和设施层面协变量及设施随机效应,并按HHI四分位数分组。
主要发现
- HHI最高四分位组患者持续使用中心静脉导管超过90天的 odds 显著低于最低四分位组(OR 0.80, 95%CI 0.75-0.87, P<0.001)。
- 该关联在多项敏感性分析中保持一致。
关键数值与推荐
- HHI最高四分位组 vs 最低四分位组:持续CVC使用>90天的OR 0.80(95%CI 0.75-0.87, P<0.001)。
临床怎么用
- 促进透析中心与血管通路外科医生建立更紧密的合作关系,可能有助于减少中心静脉导管的长期使用。
局限性
- 暴露存在错误分类可能。
- 仅纳入Medicare按服务付费保险的患者。
- 存在未测量的混杂因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE & OBJECTIVE: Reducing central venous catheter (CVC) use for hemodialysis among patients with kidney failure receiving maintenance hemodialysis is an important priority. Previous reports have suggested that partnerships between hemodialysis facilities and vascular access surgeons lead to reduced rates of CVC use. We studied whether a greater intensity of these relationships was associated with less use of CVCs. STUDY DESIGN: National retrospective cohort study. SETTING & PARTICIPANTS: 109,293 patients with kidney failure receiving maintenance hemodialysis within 4,402 facilities. EXPOSURE: Facility-level Herfindahl-Hirschman index (HHI), an established measure of market concentration used as a proxy for closeness of the relationship between hemodialysis facilities and vascular access surgeons, with higher indices suggesting closer relationships. OUTCOME: Greater than 90 days of continuous CVC use for hemodialysis in 2018. ANALYTICAL APPROACH: Mixed-effects logistic regression model including patient-level covariates, facility-level covariates, and facility random effects. Dialysis facilities were divided into quartiles based on increasing HHI. Multiple sensitivity analyses were conducted using similar models. RESULTS: Patients in facilities in the highest HHI quartile were less likely to have continued catheter use for more than 90 days than those in the lowest quartile (odds ratio, 0.80; 95% confidence interval, 0.75-0.87; P < 0.001). This association was also observed in multiple sensitivity analyses. LIMITATIONS: Misclassification of the exposure, inclusion of patients insured by Medicare Fee-for-Service, unmeasured confounding. CONCLUSIONS: More extensive partnerships between dialysis facilities and vascular access surgeons reflected by the HHI were associated with lower rates of CVC use for hemodialysis. PLAIN-LANGUAGE SUMMARY: The goal of this study was to learn if patients in dialysis facilities that partnered with surgeons (measured using a marker of market concentration) who place and maintain permanent hemodialysis vascular access grafts and fistulas experienced lower use of a temporary form of vascular access for hemodialysis, central venous catheters, which are associated with an increased risk of infection. We found that closer partnerships between hemodialysis centers and surgeons were associated with less use of catheters for the patients served by those dialysis centers. These findings may inform strategies to reduce the use of central venous catheters and improve outcomes for patients with kidney failure requiring dialysis.
引用
- Bailoor K, Oerline MK, Gurnani S, et al. Hemodialysis Facilities, Vascular Access Surgeons, and Central Venous Catheter Use: A Retrospective Cohort Study. Am J Kidney Dis. 2026. PMID: 41713836. doi:10.1053/j.ajkd.2025.11.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。